After seeing continuous strong current value growth for most of the review period, in 2020 digestive remedies is expected to turn to decline. Most categories are set to see falling sales, as a result of COVID-19.
Most people still purchase digestive remedies offline, as this is convenient if they have a problem and need such products urgently. However, due to COVID-19, sales through e-commerce are expected to increase strongly.
Kalbe Farma is expected to continue to lead digestive remedies in value terms in 2020. Its local Promag brand of antacids is expected to extend its lead.
The current value decline expected in digestive remedies is expected to quickly turn around in 2021, with a return to solid growth. However, the growth rate is not expected to be as high as the level seen in 2019, pre-pandemic.
The largest category within digestive remedies, antacids, is expected to see the second-highest current value growth rate in the forecast period. Although it is not expected to recover to the pre-COVID-19 rate of growth in 2021, the rate of increase is expected to gradually rise over the forecast period.
The strong decline seen in sales of digestive enzymes since 2018 is expected to continue in the forecast period. The Indonesian government recalled all popular brands of digestive enzymes after the BPOM, the regulatory and supervisory agency responsible for food and drug safety in Indonesia, urged their removal in 2018.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Digestive Remedies industry in Indonesia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Digestive Remedies industry in Indonesia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Digestive Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page